IP Library Granted Patent US 9,186,356
Granted Patent B2
US 9,186,356 · App. 13/343,686 · Granted Nov 17, 2015

Methods for treating frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U)

Inventors: Che-Kun James Shen (Taipei, TW); Kuen-Jer Tsai (Kaosiung, TW)
Assignee: Academia Sinica
A61K31/4433A61K31/132A61K31/138A61K31/513A61K31/55A61K31/7016
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,356
App. No.
13/343,686
Granted
Nov 17, 2015
Kind
B2
Abstract

Methods for rescuing learning, memory and/or motor function deficits associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) are disclosed. The method comprises: a) administering to an animal having FTLD-U a therapeutically effective amount of an autophagy inducer; b) causing a decrease in the amount of ubiquitinated TDP-43 aggregation forms in the brain of the animal; and c) causing an improvement of the learning, memory capacities and/or motor function of the animal.

Claims (14)

1. A method of alleviating and/or rescuing a motor function deficit associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) comprising:

administering to an animal in need of alleviating and/or rescuing the motor function deficit associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) a therapeutically effective amount of rapamycin, and thereby alleviating and/or rescuing the motor function deficit associated with the FTULD-U, wherein the animal has an early stage of frontotemporal lobar degeneration without exhibiting ubiquitinated inclusions in the forebrain thereof.

2. The method. of claim 1 , further comprising:

evaluating the motor coordination and/or balance of the animal.

3. A method of decreasing and/or alleviating the presence of ubiquitinated TDP-43, comprising:

administering to an animal in need of decreasing and/or alleviating the presence of ubiquitinated TDP-43a therapeutically effective amount of rapamycin, and thereby decreasing and/or alleviating the presence of ubiquitinated TDP-43, wherein the animal has an early stage of frontotemporal lobar degeneration without exhibiting ubiquitinated inclusions in the forebrain thereof.

4. The method of claim 3 , wherein the animal suffers from learning and/or memory impairment.

5. The method of claim 3 , further comprising:

evaluating the motor coordination and/or balance of the animal.

6. A method of alleviating and/or rescuing learning, memory and motor function deficits associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U), comprising:

administering to an animal in need of alleviating and/or rescuing the learning, memory and motor function deficits associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) a therapeutically effective amount of all autophagy inducer; and

thereby alleviating and/or rescuing the learning, memory and motor function deficits associated with FTLD-U, wherein the animal has an early stage of frontotemporal lobar degeneration exhibiting the memory and/or learning deficits but without exhibiting ubiquitinated inclusions in the forebrain thereof wherein the autophagy inducer is at least one chosen from rapamycin, tamoxifen, carbamazepine, calpastatin, minoxidil, spermidine, and trehalose.

7. The method of claim 6 , further comprising:

assessing the leanrning and/or memory capacities of the animal; and/or evaluating the motor coordination and/or balance of the animal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2012
From: SHEN, CHE-KUN JAMES; TSAI, KUEN-JER
To: ACADEMIA SINICA
Reel/Frame 027480/0652 →
Continuity (2)
Provisional Application 61430970 · Jan 8, 2011
Related Publication 20120178775A1 · Jul 12, 2012